The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ELASTIC N.V. | ORD SHS | N14506104 | 1,958 | 43,850 | SH | DFND | 1 | 43,850 | 0 | 0 | |
ALLENA PHARMACEUTICALS, INC. | COM | 018119107 | 2,173 | 2,263,365 | SH | DFND | 1 | 2,263,365 | 0 | 0 | |
FIVERR INTERNATIONAL LTD. | ORD SHS | M4R82T106 | 97,039 | 3,855,334 | SH | DFND | 1 | 3,855,334 | 0 | 0 |